Movatterモバイル変換


[0]ホーム

URL:


Skip to content

What can we help you find?

Search for:
Hero Image
Who we are >Policies & positions

Policies & positions

We aspire to be open and transparent to earn the trust and confidence of our stakeholders.

We work to achieve our business objectives responsibly for all

We support policies that promote the interest of patients, improve public health and promote access to medicines, vaccines and innovations. We develop policy positions, adopt industry-leading standards, communicate openly and seek those who share our mission.

Access & affordability

We work to save and improve lives around the world by inventing breakthrough medicines and vaccines — and ensuring they're available and affordable to patients who need them.

Innovation

Innovation is the heart of our company. That's why we support policies that promote research and development investments and put patient needs first.

Public health & environmental sustainability

We take a firm stand on many public health issues confronting people and society today, including climate change, antimicrobial resistance and using water more efficiently, to name just a few.

Transparency & responsible behavior

We're committed to ethics and human rights and are committed to achieving our business objectives responsibly for all.

Related links

related content image #1

Transparency disclosures

We aspire to be transparent about how we operate to earn the trust and confidence of our customers and other stakeholders.

related content image #2

Code of conduct & compliance

Our code of conduct details our business standards and practices.

related content image #3

Sustainability

We operate responsibly every day to enable a safe and healthy future for people and communities globally.

Forward-looking statement of Merck & Co., Inc., Rahway, N.J., USA

This website of Merck & Co., Inc., Rahway, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline candidates that the candidates will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.


Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s Annual Report on Form 10-K for the year ended December 31, 2024 and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).
No Duty to Update
The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.

DeclineAccept

You are leaving Merck.com

Continue

Welcome to Merck.com

By continuing, you will be directed to a site intended only for residents of the United States and Canada. We are called MSD everywhere, except in the United States and Canada where we are known as Merck & Co Inc, Rahway, NJ USA.

Continue

[8]ページ先頭

©2009-2025 Movatter.jp